世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

睡眠時無呼吸症候群のデバイス市場規模、シェア&トレンド分析レポート:製品タイプ別(診断デバイス、治療デバイス、睡眠時無呼吸症候群用マスク)、地域別、セグメント別予測、2022年~2030年


Sleep Apnea Devices Market Size, Share & Trends Analysis Report By Product Type (Diagnostic Devices, Therapeutic Devices, Sleep Apnea Masks), By Region, And Segment Forecasts, 2022 - 2030

睡眠時無呼吸症候群治療器市場の成長と傾向 グランドビューリサーチ社の最新レポートによると、睡眠時無呼吸症候群デバイスの世界市場規模は2030年までに69億米ドルに達すると予測されています。同市場は、202... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2022年9月27日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
150 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

睡眠時無呼吸症候群治療器市場の成長と傾向

グランドビューリサーチ社の最新レポートによると、睡眠時無呼吸症候群デバイスの世界市場規模は2030年までに69億米ドルに達すると予測されています。同市場は、2022年から2030年にかけてCAGR6.2%で拡大すると予測されています。高血圧、糖尿病、心血管疾患、肥満などの慢性疾患の蔓延が、閉塞性睡眠時無呼吸症候群(OSA)の発生率&負担を増大させています。

World Population Reviewの推計によると、米国における肥満の有病率は全人口の36.2%を占めています。研究により、OSAの有病率は年齢が上がるにつれて増加することが分かっています。寿命が延び、世界的に老年人口が増加していることが、OSAの有病率上昇に寄与していると予想されます。発展途上国や低開発国では、無呼吸装置の認知度が低く、普及率が低いため、潜在的な成長機会があると考えられます。

COVID-19の大流行により、複数の閉鎖や旅行制限が行われ、医療施設の機能に大きな支障が生じました。いくつかの医療施設ではインフラが大幅に変更され、医療従事者は選択的な処置の延期を余儀なくされました。パンデミックは、治療量に影響を与え、睡眠センター、診療所、医師の診療を一時的に停止させることにつながりました。コロナウイルスの感染率を抑制するためのこれらの措置は、診断薬市場の成長にマイナスの影響を及ぼしました。

しかし、睡眠・呼吸ケアなどの治療用機器は、パンデミックの初期に需要の急増を目撃しました。人工呼吸器の代わりにPositive Airway Pressure(気道陽圧)装置が機械的換気の代替手段として使用されるようになりました。

主要企業は、成長を促進する診断および治療需要の増加に対応するため、革新的な製品開発戦略の考案に常に注力しています。さらに、CPAPに対する耐性が低い患者のために、経口および経鼻デバイスなど、CPAPの革新的な代替手段が導入されています。

例えば、ホームケア用経口デバイスのメーカーであるGoPAPFreeは、CPAPの便利でより効果的な代替品として、2021年2月にO2Vent Optimaを発表しています。同様に、Fisher & Paykelは、2020年2月にヨーロッパ、カナダ、オーストラリア、ニュージーランド市場向けに、睡眠時無呼吸症候群の治療に使用されるコンパクトな鼻マスクであるCapFitヘッドギア付きのF&P Evoraを発売しています。

睡眠時無呼吸症候群治療器市場レポートハイライト

- 2021年の売上高シェアは治療用デバイスが79.4%で最大

- OSAの有病率の増加、認知度の向上、有名プレイヤーの存在により、2021年の売上高シェアは北米が48.7%で最大のシェアを占めた

- 2022年から2030年までのCAGRは、アジア太平洋地域が最も速く7.0%を超えると予想される。



ページTOPに戻る


目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database
1.3.1.2 GVR’s internal database
1.3.2 Primary Research
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Global Sleep Apnea Devices Market Outlook
2.2 Global Sleep Apnea Devices Market Segment Outlook
2.3 Global Sleep Apnea Devices Market Competitive Insight
2.4 Global Sleep Apnea Snapshot
Chapter 3 Global Sleep Apnea Devices Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.3.3 Industry Challenges
3.4 Global Sleep Apnea Devices Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic and Social landscape
3.4.2.3 Technology landscape
3.4.2.4 Legal landscape
3.4.2.5 Technology landscape
3.4.3 Regulatory Framework
3.4.3.1 Compliance Standards
3.4.4 Impact of COVID-19
Chapter 4 Global Sleep Apnea Devices Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Company Market Share Analysis
4.3 Company Market Position Analysis
Chapter 5 Global Sleep Apnea Devices Market: Product Type Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Sleep Apnea Devices Market: Product Type Market Share Analysis, 2021 and 2030
5.3 Diagnostic Devices
5.3.1 Diagnostic devices analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.3.2 Actigraphs analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.3.3 Polysomnography Device analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.3.4 Respiratory polygraphs analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.3.4.1 Cardiologists
5.3.4.2 ENT Specialists
5.3.4.3 Homecare Nurses
5.3.4.4 Sleep Physicians
5.3.5 Pulse oximeters analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.4 Therapeutic Devices
5.4.1 PAP devices market estimates and forecasts, 2016 - 2030 (USD Million)
5.4.4.1 Continuous Positive Airway Pressure (CPAP)
5.4.4.2 Auto - titrating Positive Airway Pressure (APAP)
5.4.4.3 Bilevel Positive Airway Pressure (BiPAP)
5.4.2 Oral devices market estimates and forecasts, 2016 - 2030 (USD Million)
5.4.3 Nasal devices market estimates and forecasts, 2016 - 2030 (USD Million)
5.4.4 Chin Straps market estimates and forecasts, 2016 - 2030 (USD Million)
5.5 Sleep Apnea Masks
Chapter 6 Global Sleep Apnea Devices Market: Regional Estimates & Trend Analysis, By Product Type
6.1 Global Sleep Apnea Devices Market: Regional Movement Analysis
6.2 North America
6.2.1 North America Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.4 France
6.3.4.1 France Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.7 Russia
6.3.7.1 Russia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.8 Portugal
6.3.8.1 Portugal Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.5 Australia
6.4.5.1 Australia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.7 Singapore
6.4.7.1 Singapore Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 UAE Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
Chapter 7 Competitive Landscape
7.1 BMC MEDICAL CO. LTD.
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 CAREFUSION CORP. (PART OF BECTON, DICKINSON, AND COMPANY)
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 GE HEALTHCARE
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 KONINKLIJKE PHILIPS N.V. (PHILIPS RESPIRONICS)
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 RESMED
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 COMPUMEDICS LIMITED
7.6.1 Company overview
7.6.2 Financial performance
7.6.4 Product benchmarking
7.6.4 Strategic initiatives
7.7 CURATIVE MEDICAL
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 FISHER & PAYKEL HEALTHCARE LIMITED
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 IMTHERA MEDICAL, INC. (PART OF LIVANOVA PLC)
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 INVACARE CORPORATION
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
7.11 ITAMAR MEDICAL LTD.
7.11.1 Company overview
7.11.2 Financial performance
7.11.4 Product benchmarking
7.11.4 Strategic initiatives
7.12 NIHON KOHDEN
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic initiatives
7.13 NATUS MEDICAL INCORPORATED
7.13.1 Company overview
7.13.2 Financial performance
7.13.3 Product benchmarking
7.13.4 Strategic initiatives
7.14 SOMNETICS INTERNATIONAL, INC.
7.14.1 Company overview
7.14.2 Financial performance
7.14.3 Product benchmarking
7.14.4 Strategic initiatives
7.15 BRAEBON MEDICAL CORPORATION
7.15.1 Company overview
7.15.2 Financial performance
7.15.3 Product benchmarking
7.15.4 Strategic initiatives

 

ページTOPに戻る


 

Summary

Sleep Apnea Devices Market Growth & Trends

The global sleep apnea devices market size is expected to reach USD 6.9 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 6.2% from 2022 to 2030. The growing prevalence of chronic disorders such as hypertension, diabetes, cardiovascular diseases, and obesity is increasing the incidence rate & burden of Obstructive Sleep Apnea (OSA).

According to World Population Review estimates, the prevalence of obesity in the U.S. accounts for 36.2% of the total population. As per studies, the prevalence of OSA increases with increasing age. The growing global geriatric population with increasing life expectancy is anticipated to contribute to the growing prevalence of OSA. Low awareness levels and poor penetration of apnea devices in developing and underdeveloped nations introduce potential growth opportunities.

The COVID-19 pandemic imposed multiple lockdowns and travel restrictions leading to significant disruptions in the functioning of healthcare facilities. Several healthcare facilities underwent significant infrastructural changes and healthcare providers were forced to postpone elective procedures. The pandemic impacted the procedural volume and led to the temporary shutdown of sleep centers, clinics, and physician practices. These measures to curb the transmission rate of coronavirus negatively impacted the diagnostics market growth.

However, therapeutic devices such as sleep & respiratory care witnessed a surge in demand during the initial months of the pandemic. Positive Airway Pressure devices were being used as an alternative to mechanical ventilation instead of ventilators.

Key players are constantly focusing on devising innovative product development strategies to serve the growing diagnostic and therapeutic demand which is driving growth. Furthermore, innovative alternatives to CPAP such as oral and nasal devices are being introduced for patients with a low tolerance for CPAP.

For instance, GoPAPFree, a manufacturer of homecare oral devices introduced O2Vent Optima in February 2021 as a convenient & more effective alternative to CPAP. Similarly, Fisher & Paykel launched F&P Evora with CapFit headgear in February 2020 which is a compact nasal mask used in sleep apnea treatment for European, Canadian, Australian, and New Zealand markets.

Sleep Apnea Devices Market Report Highlights

• The therapeutic devices segment held the largest revenue share of 79.4%. in 2021

• North America accounted for the largest revenue share of 48.7% in 2021, owing to the growing prevalence of OSA, rising awareness levels, and presence of renowned players

• Asia Pacific is expected to witness the fastest CAGR of over 7.0% from 2022 to 2030, owing to the prevalence of OSA and the rising awareness in the region



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database
1.3.1.2 GVR’s internal database
1.3.2 Primary Research
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Global Sleep Apnea Devices Market Outlook
2.2 Global Sleep Apnea Devices Market Segment Outlook
2.3 Global Sleep Apnea Devices Market Competitive Insight
2.4 Global Sleep Apnea Snapshot
Chapter 3 Global Sleep Apnea Devices Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.3.3 Industry Challenges
3.4 Global Sleep Apnea Devices Market Analysis Tools
3.4.1 Industry Analysis - Porter’s
3.4.1.1 Bargaining power of the suppliers
3.4.1.2 Bargaining power of the buyers
3.4.1.3 Threats of substitution
3.4.1.4 Threats from new entrants
3.4.1.5 Competitive rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political landscape
3.4.2.2 Economic and Social landscape
3.4.2.3 Technology landscape
3.4.2.4 Legal landscape
3.4.2.5 Technology landscape
3.4.3 Regulatory Framework
3.4.3.1 Compliance Standards
3.4.4 Impact of COVID-19
Chapter 4 Global Sleep Apnea Devices Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Company Market Share Analysis
4.3 Company Market Position Analysis
Chapter 5 Global Sleep Apnea Devices Market: Product Type Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Sleep Apnea Devices Market: Product Type Market Share Analysis, 2021 and 2030
5.3 Diagnostic Devices
5.3.1 Diagnostic devices analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.3.2 Actigraphs analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.3.3 Polysomnography Device analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.3.4 Respiratory polygraphs analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.3.4.1 Cardiologists
5.3.4.2 ENT Specialists
5.3.4.3 Homecare Nurses
5.3.4.4 Sleep Physicians
5.3.5 Pulse oximeters analysis market estimates and forecasts, 2016 - 2030 (USD Million)
5.4 Therapeutic Devices
5.4.1 PAP devices market estimates and forecasts, 2016 - 2030 (USD Million)
5.4.4.1 Continuous Positive Airway Pressure (CPAP)
5.4.4.2 Auto - titrating Positive Airway Pressure (APAP)
5.4.4.3 Bilevel Positive Airway Pressure (BiPAP)
5.4.2 Oral devices market estimates and forecasts, 2016 - 2030 (USD Million)
5.4.3 Nasal devices market estimates and forecasts, 2016 - 2030 (USD Million)
5.4.4 Chin Straps market estimates and forecasts, 2016 - 2030 (USD Million)
5.5 Sleep Apnea Masks
Chapter 6 Global Sleep Apnea Devices Market: Regional Estimates & Trend Analysis, By Product Type
6.1 Global Sleep Apnea Devices Market: Regional Movement Analysis
6.2 North America
6.2.1 North America Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.4 France
6.3.4.1 France Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.7 Russia
6.3.7.1 Russia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.3.8 Portugal
6.3.8.1 Portugal Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.5 Australia
6.4.5.1 Australia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.4.7 Singapore
6.4.7.1 Singapore Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 UAE Sleep Apnea market estimates and forecasts, by Product Type, 2016 - 2030 (USD Million)
Chapter 7 Competitive Landscape
7.1 BMC MEDICAL CO. LTD.
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 CAREFUSION CORP. (PART OF BECTON, DICKINSON, AND COMPANY)
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 GE HEALTHCARE
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 KONINKLIJKE PHILIPS N.V. (PHILIPS RESPIRONICS)
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 RESMED
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 COMPUMEDICS LIMITED
7.6.1 Company overview
7.6.2 Financial performance
7.6.4 Product benchmarking
7.6.4 Strategic initiatives
7.7 CURATIVE MEDICAL
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 FISHER & PAYKEL HEALTHCARE LIMITED
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 IMTHERA MEDICAL, INC. (PART OF LIVANOVA PLC)
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 INVACARE CORPORATION
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives
7.11 ITAMAR MEDICAL LTD.
7.11.1 Company overview
7.11.2 Financial performance
7.11.4 Product benchmarking
7.11.4 Strategic initiatives
7.12 NIHON KOHDEN
7.12.1 Company overview
7.12.2 Financial performance
7.12.3 Product benchmarking
7.12.4 Strategic initiatives
7.13 NATUS MEDICAL INCORPORATED
7.13.1 Company overview
7.13.2 Financial performance
7.13.3 Product benchmarking
7.13.4 Strategic initiatives
7.14 SOMNETICS INTERNATIONAL, INC.
7.14.1 Company overview
7.14.2 Financial performance
7.14.3 Product benchmarking
7.14.4 Strategic initiatives
7.15 BRAEBON MEDICAL CORPORATION
7.15.1 Company overview
7.15.2 Financial performance
7.15.3 Product benchmarking
7.15.4 Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

Grand View Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る